OptiBiotix Health PLC - York-based life sciences firm - Says Finance Director Graham Myers will step down on November 30 and be replaced by David Blain, who will join as acting Finance Director on November 1. David Blain is currently financial director at Iksuda Therapeutics Ltd.

The company also notes that Chief Executive Officer Stephen O’Hara is currently recovering from a short illness, and is expected back at work ‘shortly’.

Current stock price: 10.36 pence, down 6.2% in London on Wednesday afternoon

12-month change: down 64%

Copyright 2024 Alliance News Ltd. All Rights Reserved.